Company / Capital Expenditures
BIO-PATH HOLDINGS, INC. Capital Expenditures History
FY2012-FY2018 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$17.0K
FY2018
5-year range
$0 / $538.0K
FY2014-FY2018
Trend
-96.8%
vs FY2017
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Capital Expenditures has fluctuated over the past 7 years, ranging from $0 in FY2015 to $538,000 in FY2017.
Based on SEC 10-K filings.
$17,000 in FY2018.
Declined from $338,000 to $17,000 over the past 2 years.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2018, capital expenditures decreased 96.8% year-over-year.
- Peak capital expenditures was recorded in FY2017.
- Lowest capital expenditures in the period was in FY2015.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -25.76 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2018 | $17.0K | -96.8% |
| FY2017 | $538.0K | +59.2% |
| FY2016 | $338.0K | - |
| FY2015 | $0 | -100.0% |
| FY2014 | $123.0K | - |
| FY2013 | $0 | - |
| FY2012 | $0 | - |
As of FY2018 · SEC 10-K · Updated Jun 29, 2026